Lucintel Forecasts The Global Cardiovascular Device Market To Reach $116 Billion By 2030

By Author: Lucintel
Total Articles: 6221
Comment this article

According to the recent study the cardiovascular device market is projected to reach an estimated $116 billion by 2030 at a CAGR of 5% from 2023 to 2030. Growth in this market is primarily driven by growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population.
A more than 150 page report to understand trends, opportunity and forecast in cardiovascular device market by type (cardiac rhythm management, interventional cardiac devices, peripheral vascular devices, cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology, and diagnostic & monitoring devices), by device (pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that the structural heart device and electrophysiology are expected to be fastest growing segment during the forecast period due to an increase in the geriatric population burdened with various degenerative heart diseases.
CRM segment is expected to remain ...
... the largest segment. Increasing use of defibrillators mainly due to its cost effectiveness and safety is expected to result in significant growth of the CRM market.
Download sample by clicking on cardiovascular device market
North America is expected to remain the largest market during the forecast period mainly due to presence of a large size target patient pool coupled with high adoption rate for advanced treatments in this region.
Medtronic Public Limited Company, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, and Johnson & Johnson are the major supplier in cardiovascular device market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Orthopedic Orthotic Market
Pruritus Therapeutic Market
Retinal Implant Market
Ringworm Treatment Market
Shock Wave Therapy Device Market
Tendon Repair Market